Latest papers

Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected children.

Clinical utility of current NNRTIs and perspectives of new agents in this class under development.

In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors).

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies.

Pfizer announces free drug program.

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.

Protease inhibitor-sparing regimens: new evidence strengthens position.

Pharmacokinetics of ritonavir and delavirdine in human immunodeficiency virus-infected patients.

Toxicity of non-nucleoside analogue reverse transcriptase inhibitors.

Pharmacia pilots patent share for HIV drug.

Delavirdine malabsorption in HIV-infected subjects with spontaneous gastric hypoacidity.

Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.

Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.

Effect of delavirdine on plasma lipids and lipoproteins in patients receiving antiretroviral therapy.

Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.

Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection.

Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.

Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.